Crystallographic Automation
晶体学自动化
基本信息
- 批准号:7793204
- 负责人:
- 金额:$ 49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2011-07-14
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAutomationCollaborationsCrystallizationCrystallographyCulicidaeDiseaseDropsFundingGoalsHealthHumanImageLaboratoriesLeadLipidsMembrane ProteinsMinorMolecularMonitorNucleotidesPhaseProteinsReactionRequest for ProposalsResearch PersonnelRobotRoboticsRoentgen RaysSamplingSiteStructureTechniquesTherapeuticTimeTranslational ResearchTransportationUniversitiesWorkdesignexperienceimprovedinsightinterestmacromoleculenanolitreoutreachprotein structureresearch studystructural biologysuccess
项目摘要
DESCRIPTION (provided by applicant): Over the past 10 years, it has become clear that imaging the atomic structures of macromolecules is important for both determining the molecular mechanisms of disease and to design therapeutics. This has lead to an increase in interest in determining crystal structures of proteins and nucleotides. For X-ray crystallographic studies, the identification of initial crystallization conditions is essential, but can take hundreds of trials for a soluble protein, and tens of thousands of trials for a membrane protein. This makes approaching these experiments daunting for researchers without prior experience in the field, and can inhibit collaborations between laboratories that use crystallography as a primary technique and laboratories focused on function. The proposal requests funds to enhance the crystallographic automation at Vanderbilt University through the purchase one robot for the crystallization of membrane proteins in cubic lipid phases (CLP) from Zinsserna (Northridge, CA) and one automated imager from Formulatrix (Waltham, MA) to document the time- course of crystallization reactions. The two goals of this purchase are: 1) to enhance the capabilities for crystallization of membrane proteins, and 2) to improve the capacity of the automated crystallization facility to allow outreach to researchers that do not specialize in structural biology. This proposal is currently endorsed by 14 laboratories at Vanderbilt University and the Vanderbilt University Medical Center, with 4 major users and 10 minor users. While these groups have had success using crystallographic automation consisting of a Mosquito nano-liter drop setter, there is no robot that can pipette the lipid phase within 1,000 miles. The expansion of the local crystallization robotic facility to include a module that pippettes the cubic lipid phase will have a broad positive impact on NIH-sponsored basic and translational research at Vanderbilt. Moreover, transportation of samples off-site to using imaging facilities will destroy these samples. Thus the on-campus ability to monitor an increased number of crystallization reactions will expand the number of laboratories that can use structural techniques as a part of their repertoire as they approach problems of human health.
HEALTH RELEVANCE: The determination of structures of macromolecules can provide insight into the basic mechanisms of function and mis-function. To better approach difficult problems in crystallization, we propose to purchase a crystallization robot designed to work with membrane proteins, and an automated imager.
描述(由申请人提供):在过去的10年中,人们已经清楚地认识到,大分子的原子结构成像对于确定疾病的分子机制和设计治疗方法都很重要。这导致了对确定蛋白质和核苷酸的晶体结构的兴趣增加。对于X射线晶体学研究,初始结晶条件的确定是必不可少的,但对于可溶性蛋白质可能需要数百次试验,对于膜蛋白质可能需要数万次试验。这使得没有该领域经验的研究人员难以进行这些实验,并且可能会抑制使用结晶学作为主要技术的实验室与专注于功能的实验室之间的合作。该提案要求提供资金,通过从Zinsserna(Northridge,CA)购买一台用于立方脂质相(CLP)中膜蛋白结晶的机器人和从Formulatrix(Waltham,MA)购买一台自动成像仪来记录结晶反应的时间过程,以提高范德比尔特大学的结晶自动化。此次收购的两个目标是:1)提高膜蛋白结晶的能力,2)提高自动结晶设施的能力,以便与不专门从事结构生物学的研究人员进行联系。该提案目前得到了范德比尔特大学和范德比尔特大学医学中心14个实验室的认可,其中有4个主要用户和10个次要用户。虽然这些研究小组已经成功地使用了由Moscow纳升液滴设置器组成的晶体自动化,但没有机器人可以在1,000英里内移液脂质相。本地结晶机器人设施的扩展,包括一个模块,移液立方脂质相将有一个广泛的积极影响,在范德比尔特NIH赞助的基础和转化研究。此外,将样本运至场外使用成像设施将破坏这些样本。因此,校园内监测越来越多的结晶反应的能力将扩大可以使用结构技术作为其解决人类健康问题的一部分的实验室数量。
健康相关性:测定大分子的结构可以深入了解功能和功能失调的基本机制。为了更好地解决结晶中的难题,我们建议购买一台用于膜蛋白的结晶机器人和一台自动成像仪。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structural Elucidation of Peptide Binding to KLHL-12, a Substrate Specific Adapter Protein in a Cul3-Ring E3 Ligase Complex.
肽与 KLHL-12(Cul3 环 E3 连接酶复合物中的底物特异性接头蛋白)结合的结构阐明。
- DOI:10.1021/acs.biochem.9b01073
- 发表时间:2020
- 期刊:
- 影响因子:2.9
- 作者:Zhao,Bin;Payne,WilliamG;Sai,Jiqing;Lu,Zhenwei;Olejniczak,EdwardT;Fesik,StephenW
- 通讯作者:Fesik,StephenW
A New Family of HEAT-Like Repeat Proteins Lacking a Critical Substrate Recognition Motif Present in Related DNA Glycosylases.
一个新的 HEAT 样重复蛋白家族,缺乏相关 DNA 糖基化酶中存在的关键底物识别基序。
- DOI:10.1371/journal.pone.0127733
- 发表时间:2015
- 期刊:
- 影响因子:3.7
- 作者:Mullins,ElwoodA;Shi,Rongxin;Kotsch,LyleA;Eichman,BrandtF
- 通讯作者:Eichman,BrandtF
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T M Iverson其他文献
T M Iverson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T M Iverson', 18)}}的其他基金
Molecular basis for arrestin-mediated signaling
抑制蛋白介导的信号传导的分子基础
- 批准号:
9324338 - 财政年份:2016
- 资助金额:
$ 49万 - 项目类别:
Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogens
革兰氏阳性病原体富含丝氨酸的粘附素的配体结合机制
- 批准号:
8788229 - 财政年份:2014
- 资助金额:
$ 49万 - 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
- 批准号:
8362282 - 财政年份:2011
- 资助金额:
$ 49万 - 项目类别:
Stabilization of Membrane Protein Signaling Complexes
膜蛋白信号复合物的稳定性
- 批准号:
8310115 - 财政年份:2010
- 资助金额:
$ 49万 - 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
- 批准号:
8170283 - 财政年份:2010
- 资助金额:
$ 49万 - 项目类别:
Stabilization of Membrane Protein Signaling Complexes
膜蛋白信号复合物的稳定性
- 批准号:
8519131 - 财政年份:2010
- 资助金额:
$ 49万 - 项目类别:
相似海外基金
Treecle - data and automation to unlock woodland creation in the UK to achieve net zero
Treecle - 数据和自动化解锁英国林地创造以实现净零排放
- 批准号:
10111492 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
SME Support
STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
- 批准号:
2332121 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Cooperative Agreement
Improving access to AI automation to support new digital offerings within Professional/Financial Services
改善对人工智能自动化的访问,以支持专业/金融服务中的新数字产品
- 批准号:
10095096 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Collaborative R&D
Cost-Effective, AI-driven Automation Technology for Cell Culture Monitoring: Boosting Efficiency and Sustainability in Industrial Biomanufacturing and Streamlining Supply Chains
用于细胞培养监测的经济高效、人工智能驱动的自动化技术:提高工业生物制造的效率和可持续性并简化供应链
- 批准号:
10104748 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Launchpad
Sustainable Remanufacturing solution with increased automation and recycled content in laser and plasma based process (RESTORE)
可持续再制造解决方案,在基于激光和等离子的工艺中提高自动化程度和回收内容(RESTORE)
- 批准号:
10112149 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
EU-Funded
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
- 批准号:
10087446 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Collaborative R&D
SBIR Phase II: Radar-based Building Automation
SBIR 第二阶段:基于雷达的楼宇自动化
- 批准号:
2335079 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Cooperative Agreement
Automation and cost reduction of the hardware and software components of a novel indoor sustainable vertical growing solution
新型室内可持续垂直种植解决方案的硬件和软件组件的自动化和成本降低
- 批准号:
83007861 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Innovation Loans
Artificial intelligence coupled to automation for accelerated medicine design
人工智能与自动化相结合,加速药物设计
- 批准号:
EP/Z533038/1 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Research Grant
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 49万 - 项目类别:
Collaborative R&D